Meeder Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Meeder Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,718	Closed	-$75K	–	2716
2021 Q2	$75K	Sell	2,718 -618	-19%	-$12.1K	﹤0.01%	992
2021 Q1	$56K	Buy	+3,336	New	+$76K	﹤0.01%	1070
2020 Q4	–	Sell	-3,103	Closed	-$43K	–	2388
2020 Q3	$43K	Buy	3,103 +160	+5%	+$2.47K	﹤0.01%	985
2020 Q2	$52K	Buy	2,943 +1,290	+78%	+$19.5K	﹤0.01%	916
2020 Q1	$16K	Buy	+1,653	New	+$13.5K	﹤0.01%	1344

Meeder Asset Management's TBIO Position: Q3 2021 in Review

Meeder Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 2,718 shares — an estimated $75K sold.

Meeder Asset Management first reported a position in TBIO in Q1 2020 and held it in 5 quarters. The position peaked at $75K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Meeder Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Meeder Asset Management sold 2,718 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $75K.
Meeder Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
Meeder Asset Management's Translate Bio, Inc. Common Stock position peaked at $75K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Meeder Asset Management's 13F filing for Q3 2021, filed 8 Nov 2021.